Hyderabad: Hypertension remains one of India’s most pressing public health challenges, with an estimated 20 crore adults affected, according to the India Hypertension Control Initiative. Medical experts from AIG Hospitals, including Dr. Rajeev Menon, Dr. Anuj Kapadiya, Dr. Swaroop G Bharadi, and Dr. Prasada Reddy, highlighted the growing prevalence of hypertension and resistant hypertension, discussing innovative therapies such as renal denervation (RDN) that have shown promising results in controlling blood pressure. Resistant hypertension often progresses gradually, manifesting as headaches, dizziness, breathlessness, or occasional chest discomfort. Experts emphasized that better blood pressure control can lower risks of heart attack, stroke, kidney disease, and long-term healthcare costs, enabling patients to lead healthier and more active lives. Hypertension control, especially in resistant cases, remains critical for both individual wellbeing and broader public health outcomes, with therapies like renal denervation offering renewed hope.